-
Prognostic Value of C-Reactive Protein-to-Lymphocyte Ratio in Combined Immunotherapy and Chemotherapy for Small Cell Lung Cancer
16 Jul 2025 17:40 GMT
… 20% of all lung cancers.2 Recent advancements … nab-paclitaxel, and irinotecan. Treatment continued with maintenance … with advanced small cell lung cancer. Lung Cancer. 2017;8:249– … and advanced lung cancer inflammation index (ALI). Transl Lung Cancer Res. …
-
A Systematic Review of SNPs Screening for Platinum-Related Pharmacodynamics and Pharmacokinetics Genes in Non-Small Cell Lung Cancer for Precision Medicine
26 Jun 2025 22:33 GMT
… lung cancer patients treated with platinum-based chemotherapy. Lung Cancer. … non-small cell lung cancer patients. Lung Cancer. 2011;72 … ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical … lung cancer: 2009 looking toward 2012. Chin J Lung Cancer …
-
FDA’s Published CRLs Deliver Insight Into the Drug Approval Process
16 Jul 2025 17:44 GMT
… breast cancer, non–small cell lung cancer (NSCLC), and pancreatic cancer.11 … ; mCRC in combination with fluoropyrimidine-irinotecan– or fluoropyrimidine-oxaliplatin–based chemotherapy …
-
Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers
16 Jul 2025 17:16 GMT
… for relapsed small cell lung cancer (SCLC) whereas emerging … disease.14,15
Lung Cancer
Tarlatamab Significantly Improves … NSCLC Treatment Landscape
Lung cancer research has been … or folinic acid, fluorouracil, irinotecan hydrochloride (Camptosar; Pfizer), …
-
Feasibility and Safety of Anlotinib Combined with Immune Checkpoint Inhibitors in Patients with Previously Immunotherapy-Treated Extensive-Stage Small Cell Lung Cancer: A Retrospective Exploratory Study
09 Jun 2025 10:12 GMT
… small cell lung cancer: a retrospective cohort study. Transl Lung Cancer Res. … the study of lung cancer--what limits limited disease? Lung Cancer. 2002;37 … irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer. Lung Cancer …
-
OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Vaccine Tedopi® in Pancreatic Cancer and Non-Small Cell Lung Cancer
02 Jun 2025 16:00 GMT
… and Non-Small Cell Lung Cancer
Two presentations at the … results at ASCO. In lung cancer, patient recruitment is progressing … metastatic non-small cell lung cancer and secondary resistance to … folinic acid, fluorouracil and irinotecan
2 FOLFIRINOX: A combination …
-
Therapeutic Effect of Brucea Javanica Oil Emulsion in Mice with Irinotecan-Induced Delayed Diarrhea
23 Jun 2025 12:52 GMT
… efficacy in alleviating irinotecan-induced delayed diarrhea … Administration for marketing (230601036). Irinotecan (purity ≥ 98%) was … effect in ameliorating irinotecan-induced delayed diarrhea. … colorectal, pancreatic, and lung cancers,20,21 is limited …
-
Adebrelimab in Small Cell Lung Cancer: From Current Advances to Emerging Combination Strategy and Challenge
31 May 2025 15:01 GMT
… adebrelimab combined with irinotecan liposomes in patients … sites and survival in lung cancer. Lung Cancer. 2014;86(1 … cell lung cancer: a multicenter retrospective analysis. Transl Lung Cancer Res … lung cancer progressing after 2 lines of therapy. Lung Cancer. …
-
ASCO: Roche, Jazz's Zepzelca small cell lung cancer win leaves room for improvement
23 May 2025 00:55 GMT
… position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca … line extensive-stage small cell lung cancer (ES-SCLC) significantly … or in combination with irinotecan against the physician’s … choice of topotecan or irinotecan.
Jazz in-licensed U …
-
Seven lung cancer companies advancing new treatments in 2025
20 May 2025 13:28 GMT
… EGFR ex20ins inhibitor
Lead lung cancer candidate: Zipalertinib
Recent … Jazz Pharmaceuticals’ lead lung cancer drug is called Zepzelca … or in combination with irinotecan (a type of … settings outside of lung cancer.
Lung cancer treatment market expected …
About
© 1995-2025